When: 8:30 am - 4:30 pm, Saturday, November 12, 2011
Where: Institute of Americas, UCSD
Organizer: Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA)
Registration: https://www.123signup.com/register?id=ccqhj
$20 for early birds by Nov 8; $50 for onsite registration. $10 off for students and postdocs. Fees include program brochure, continental breakfast, coffee, lunch and onsite reception. Online registration closes on Nov 9.
Event Program
8:30 am Breakfast and Registration
9:00 am Opening Remarks
Peter Zhu, President, SABPA; San Diego Chapter
Yung-Chih Wang, Ph.D., MBA, Chair, Pacific Alliance Committee, SABPA; VP, Corporate Development, China, HUYA Bioscience International
9:10 am BioAccelerating Drug Development
Jay Short, Ph.D., Chairman and CEO, BioAtla
9:30 am A brief review on cell culture based manufacturing processes and technology drivers over the past 25 years
Wolfgang Noe, Ph.D., VP of Technical Operations, Agensys
10:00 am Developing an International IP Strategy that Includes Biotherapeutic Technologies
Jerry Hefner, Ph.D., J.D., Partner, Knobbe Martens Olson & Bear LLP
10:30 am Coffee Break
10:50 am Panel Discussion: Biotherapeutics
Session Leader: Hui Li, Ph.D., Chairman of the Board, SABPA; Director of Business Development, Bioduro, a PPD company
Panel Speakers:
Kevin Chen, VP, China General Manager and Co-Founder, Innovent Biologics, Inc.
William Lee, Ph.D., CEO, NOD Pharmaceuticals, Inc.
Xuehai Tan, CEO, HD Biosciences
Xiaodong Yang, President and CEO, Apexigen
12:00 am Lunch
1:20 pm Opening of Afternoon Sessions
Stephanie Shi, Ph.D., Co-Chair, Pacific Alliance, SABPA; Integrated Sourcing Lead, External Research Solutions, Pfizer
1:30 pm Partnering for a Healthy World: Pfizer External R&D Overview and Asia/Pacific Strategy
Yuan-Hua Ding, Ph.D., Sr. Director, External R&D Innovation, Pfizer
2:00 pm From Generics to Innovative Medicine in China – Strategies, Challenges, and Outlook
Peng Wang, Ph.D., CSO, Simcere Pharmaceutical Group
2:30 pm Coffee Break
2:50 pm Panel Discussion: Pharmaceutical Innovations
Session Leader: Sergio Gurrieri, Ph.D., MBA, Investor, Tech Coast Angels
Panel Speakers:
Chunlin Chen, Ph.D., CEO, Medicilon
Tina Huang, General Manager, Preclinical Services, Pharmaron
Larry Wang, President, Genscript
Ming Guo, Ph.D., Co-Founder & COO, Ascentage Pharma
Xifu Liu, Ph.D., President, Zensun USA, Inc.
4:20 pm Closing Remarks
Mingzhu Zhang, Ph.D., Executive VP, SABPA; VP of Business Development, Shanghai Medicilon
4:30 pm Onsite Reception